Skip to main content
Clinical Trials/NCT04654754
NCT04654754CompletedNot Applicable

Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy: a Randomized Cross-over Trial

Jie Li1 site in 1 country12 target enrollmentStarted: December 23, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12
Locations
1
Primary Endpoint
Aerosol Particle Concentrations With Size of <0.3 Micrometer at 1 Foot Away From the Patient

Study Overview

Brief Summary

For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened to the room air, the aerosol particles generated by the patients would be directly dispersed into the room air, which might be an direct resource of virus transmission. However, the transmission risk has not been evaluated and the appropriate humidification therapy is unknown. Thus this study is aimed to investigate the aerosol particle concentrations among different oxygen devices for spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk.

Detailed Description

The transmission route of the SARS-CoV-2 virus remains controversial, and concerns persist of potentially increased virus transmission when utilizing high-flow devices and aerosol devices among COVID-19 patients. For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened to the room air, the aerosol particles generated by the patients would be directly dispersed into the room air, which might be an direct resource of virus transmission. However, the transmission risk of tracheostomy during spontaneous breathing has not been evaluated and the appropriate humidification therapy is unknown. Thus this study is aimed to investigate the aerosol particle concentrations among different oxygen devices for spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Masking Description

the device utilized in the study will be labeled as 1,2,3,4 and 5, the investigator who performed the statistical analysis will be blinded for the device

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •tracheostomy;
  • •able to spontaneous breathing without ventilator support

Exclusion Criteria

  • •confirmed diagnosis of COVID-19 within recent two weeks;
  • •non-English speaking;
  • •refuse to participate in the study;
  • •palliative care;
  • •receiving ECMO;
  • •unable to connect with tracheostomy adapter, such as laryngectomy tube

Arms & Interventions

high-flow high humidity oxygen device with tracheostomy adapter

Experimental

This device provides high-flow gas to tracheostomy patients with heat and humidification. A special adapter is used to connect the tracheostomy tube and circuit.

Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)

large-volume nebulizer (cool aerosol) with trach collar

Active Comparator

This device is the conventional device that is commonly utilized to provide humidification for spontaneous breathing patients with tracheostomy.

Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)

Venturi-adapter with trach collar

Placebo Comparator

This device did not provide any humidification but only oxygen

Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)

large-volume nebulizer (cool aerosol) with T-piece and a filter

Experimental

this device is added with a filter, in order to reduce aerosol particle concentrations in the surrounding environment

Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)

high-flow high humidity device with a scavenger or a surgical mask

Experimental

this device is added with a scavenger or a surgical mask over the adapter, in order to reduce aerosol particle concentrations in the surrounding environment

Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)

Outcomes

Primary Outcomes

Aerosol Particle Concentrations With Size of <0.3 Micrometer at 1 Foot Away From the Patient

Time Frame: 5 minutes after using the device

aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient

Aerosol Particle Concentrations With Size of 1-3 Micrometer at 1 Foot Away From the Patient

Time Frame: 5 minutes after using the device

aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient

Aerosol Particle Concentrations With Size of 0.3-0.5 Micrometer at 1 Foot Away From the Patient

Time Frame: 5 minutes after using the device

aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient

Aerosol Particle Concentrations With Size of 5-10 Micrometer at 1 Foot Away From the Patient

Time Frame: 5 minutes after using the device

aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient

Aerosol Particle Concentrations With Size of 3-5 Micrometer at 1 Foot Away From the Patient

Time Frame: 5 minutes after using the device

aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient

Aerosol Particle Concentrations With Size of 0.5-1 Micrometer at 1 Foot Away From the Patient

Time Frame: 5 minutes after using the device

aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient

Secondary Outcomes

  • Patient Comfort With Different Oxygen Devices(5 minutes after using the device)

Investigators

Sponsor
Jie Li
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Jie Li

Associate professor

Rush University Medical Center

Study Sites (1)

Loading locations...

Similar Trials